Tetrahydrozoline

Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].

84-22-0

Tetryzoline

12352005

H302

Adrenergic Receptor

GPCR/G Protein; Neuronal Signaling

Neuroscience-Neuromodulation

Cardiovascular Disease

99.32

DMSO : 100 mg/mL (ultrasonic)

C1(C2CCCC3=C2C=CC=C3)=NCCN1

C13H16N2

200.28

H302

[1]E Kisilevsky, et al. Anterior and posterior segment vasculopathy associated with long-term use of tetrahydrozoline. CMAJ. 2018 Oct 9;190 (40) :E1208.|[2]Judy Peat, et al.Determination of tetrahydrozoline in urine and blood using gas chromatography-mass spectrometry (GC-MS) . Methods Mol Biol. 2010;603:501-8.|[3]Danuta Nowakowska, et al. In vitro effects of vasoconstrictive retraction agents on primary human gingival fibroblasts. Exp Ther Med. 2020 Mar; 19 (3) : 2037-2044.

Blue Ice

-20°C (Powder, protect from light)

http://file.medchemexpress.com/batch_PDF/HY-B0556/Tetrahydrozoline-SDS-MedChemExpress.pdf

Reference compound1

Launched